Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Biogrip Forte is an over-the-counter (OTC) combination medication developed and marketed by Laboratorios Elea Phoenix for the symptomatic treatment of influenza and the common cold. The product is a multi-ingredient small molecule therapy containing paracetamol (analgesic and antipyretic), phenylephrine (nasal decongestant), and carbepentane (antitussive), supplemented with vitamins B1 (thiamine) and C (ascorbic acid). It is specifically indicated for intense flu symptoms, including fever, pain, nasal congestion, and cough with phlegm. Laboratorios Elea Phoenix acquired the Bio-Grip brand from Sanofi in March 2020, and the product is currently part of Elea's OTC product line in Argentina.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Biogrip Forte.